---
title: "Guided Therapeutics, Inc. (GTHP.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/GTHP.US.md"
symbol: "GTHP.US"
name: "Guided Therapeutics, Inc."
industry: "Health Care Equipment"
---

# Guided Therapeutics, Inc. (GTHP.US)

| Item | Detail |
|------|--------|
| Industry | Health Care Equipment |
| Location | US Market |
| Website | [www.guidedinc.com](https://www.guidedinc.com) |

## Company Profile

Guided Therapeutics, Inc., a medical technology company, develops medical devices. It focuses on the marketing and sale of LuViva, an advanced cervical scan non-invasive cervical cancer detection device that identifies cervical cancers and precancers painlessly, non-invasively, and at the point-of-c...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-17T04:30:11.000Z

**Overall: C (0.54)**

**Industry**: Health Care Equipment

| Metric | Value |
|--------|-------|
| Industry Ranking | 96 / 184 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Blend - Stocks in which the company has both growth and mature businesses.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 368.42% |  |
| Net Profit YoY | -18.81% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | -3.82 |  |
| Dividend Ratio | 0.00% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 27.74M |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 178000.00 |  |


**Multi Score**: C

#### Profit Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 36.89% | A |
| Profit Margin | -1477.53% | E |
| Gross Margin | 58.33% | B |

#### Growth Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 368.42% | A |
| Net Profit YoY | -18.81% | D |
| Total Assets YoY | -27.70% | E |
| Net Assets YoY | -14.80% | E |

#### Cash Score: B

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | -6.35% | D |
| OCF YoY | 368.42% | A |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.17 | D |

#### Debt Score: E

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 725.25% | E |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Guided Therapeutics, Inc.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "B",
      "indicators": [
        {
          "name": "ROE",
          "value": "36.89%",
          "rating": "A"
        },
        {
          "name": "Profit Margin",
          "value": "-1477.53%",
          "rating": "E"
        },
        {
          "name": "Gross Margin",
          "value": "58.33%",
          "rating": "B"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "B",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "368.42%",
          "rating": "A"
        },
        {
          "name": "Net Profit YoY",
          "value": "-18.81%",
          "rating": "D"
        },
        {
          "name": "Total Assets YoY",
          "value": "-27.70%",
          "rating": "E"
        },
        {
          "name": "Net Assets YoY",
          "value": "-14.80%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "B",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "-6.35%",
          "rating": "D"
        },
        {
          "name": "OCF YoY",
          "value": "368.42%",
          "rating": "A"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.17",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "E",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "725.25%",
          "rating": "E"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | Inspire Medical (US.INSP) | A | B | A | A | B | A |
| 02 | Delcath (US.DCTH) | C | A | A | A | A | A |
| 03 | Intuitive Surgical (US.ISRG) | A | B | C | A | B | B |
| 04 | Stryker (US.SYK) | A | B | C | C | B | B |
| 05 | Boston Scientific (US.BSX) | B | B | E | A | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -9.89 | 142/181 | - | - | - |
| PB | -3.82 | 155/181 | - | - | - |
| PS (TTM) | 155.85 | 142/181 | 11047.43 | 196.96 | 164.54 |
| Dividend Yield | 0.00% | - | - | - | - |

## References

- [Company Overview](https://longbridge.com/en/quote/GTHP.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/GTHP.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/GTHP.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.